Gri Bio Etf Shares Outstanding
| GRI Etf | USD 0.30 0.03 9.09% |
GRI Bio fundamentals help investors to digest information that contributes to GRI Bio's financial success or failures. It also enables traders to predict the movement of GRI Etf. The fundamental analysis module provides a way to measure GRI Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GRI Bio etf.
GRI |
GRI Bio ETF Shares Outstanding Analysis
GRI Bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current GRI Bio Shares Outstanding | 976.19 K |
Most of GRI Bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GRI Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GRI Shares Outstanding Historical Pattern
Today, most investors in GRI Bio Etf are looking for potential investment opportunities by analyzing not only static indicators but also various GRI Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of GRI Bio shares outstanding as a starting point in their analysis.
GRI Bio Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, GRI Bio has 976.19 K of shares currently outstending. This is much higher than that of the Biotechnology family and significantly higher than that of the Health Care category. The shares outstanding for all United States etfs is notably lower than that of the firm.
GRI Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GRI Bio's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of GRI Bio could also be used in its relative valuation, which is a method of valuing GRI Bio by comparing valuation metrics of similar companies.GRI Bio is currently under evaluation in shares outstanding as compared to similar ETFs.
Fund Asset Allocation for GRI Bio
The fund invests 99.63% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides GRI Bio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
GRI Fundamentals
| Return On Asset | -2.92 | ||||
| Current Valuation | (3.1 M) | ||||
| Shares Outstanding | 976.19 K | ||||
| Shares Owned By Insiders | 17.75 % | ||||
| Shares Owned By Institutions | 4.59 % | ||||
| Number Of Shares Shorted | 24.33 K | ||||
| Price To Earning | 23.35 X | ||||
| EBITDA | (11.33 M) | ||||
| Net Income | (13.04 M) | ||||
| Cash And Equivalents | 183.82 M | ||||
| Cash Per Share | 0.30 X | ||||
| Total Debt | 14 K | ||||
| Debt To Equity | 1.23 % | ||||
| Current Ratio | 5.23 X | ||||
| Book Value Per Share | 5.27 X | ||||
| Cash Flow From Operations | (9.14 M) | ||||
| Short Ratio | 0.08 X | ||||
| Earnings Per Share | (31.50) X | ||||
| Market Capitalization | 746.78 K | ||||
| Total Asset | 2.96 M | ||||
| Retained Earnings | (31.53 M) | ||||
| Working Capital | 237 K | ||||
| Current Asset | 1.22 B | ||||
| Current Liabilities | 243.82 M | ||||
| One Year Return | 12.82 % | ||||
| Three Year Return | 8.99 % | ||||
| Five Year Return | 5.20 % | ||||
| Ten Year Return | 8.79 % | ||||
| Net Asset | 2.96 M | ||||
| Last Dividend Paid | 0.51 | ||||
| Equity Positions Weight | 99.63 % |
About GRI Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GRI Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GRI Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GRI Bio based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out GRI Bio Piotroski F Score and GRI Bio Altman Z Score analysis. For more detail on how to invest in GRI Etf please use our How to Invest in GRI Bio guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
The market value of GRI Bio is measured differently than its book value, which is the value of GRI that is recorded on the company's balance sheet. Investors also form their own opinion of GRI Bio's value that differs from its market value or its book value, called intrinsic value, which is GRI Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GRI Bio's market value can be influenced by many factors that don't directly affect GRI Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GRI Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if GRI Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GRI Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.